Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021 [Japanese GAAP](Consolidated)
November 10, 2020
Name of listed company:

SHIP HEALTHCARE HOLDINGS, INC.
Shares listed on: Tokyo Stock Exchange
Code:
3360
URL
https://www.shiphd.co.jp/
Representative:(Title) Chairman and CEO(Name) Kunihisa Furukawa
Contact:(Title) Executive Director(Name) Hiroshi YokoyamaTel.: +81-6-6369-0130
Scheduled date for filing quarterly report: November 13, 2020 Scheduled start date of dividend payments: –Supplementary briefing materials on results:
Yes
Briefing on quarterly results:
Yes (for institutional investors and analysts)(All figures are rounded down to the nearest million yen.)

1. Consolidated financial results for the second quarter of the fiscal year ending March 31, 2021
(April 1 – September 30, 2020)(1) Consolidated operating results (cumulative)
Net sales(Percentages represent year-on-year changes.)
Profit attributable toOrdinary profit
owners of parent

Operating profit(Millions yen)%

(Millions yen)%

(Millions yen)

Q2 FY ending March 2021
220,731(8.9)
7,832(22.3)Q2 FY ended March 2020
242,232
19.8
10,08160.9
Note: Comprehensive income: Q2 FY ending March 2021: ¥ 6,352 million ((10.6) %)Q2 FY ended March 2020: ¥7,106 million (40.9 %)Diluted net income per
Net income per share
share
Q2 FY ending March 2021
Q2 FY ended March 2020

(Yen)

(Yen)

99.64
140.5490.37
127.65

8,268
10,999%(Millions yen)%

(24.8)
66.6

4,711
6,693

(29.6)
67.6(2) Consolidated financial condition
Total assets

Net assets(Millions yen)

Equity capital ratio(Millions yen)%

Q2 FY ending March 2021
300,421
107,026
34.5
FY ended March 2020
308,873
104,68133.0
Reference: Equity: Q2 FY ending March 2021: ¥103,515 million; FY ended March 2020: ¥101,784 million

2. Dividends
End Q1(Yen)

End Q2

Annual dividends
End Q3(Yen)

Year-end

Total

(Yen)

(Yen)

(Yen)

FY ended March 2020–
0.00–
FY ending March 2021–
0.00
FY ending March 2021–
(forecast)
Notes: Revisions made in most recently announced dividend forecasts: None

75.00

75.00

77.00

77.00

3. Forecast of consolidated financial results for fiscal year ending March 31, 2021
(April 1, 2020 – March 31, 2021)(Percentages represent changes from previous year.)
Profit attributable to Net income per
Net sales
Operating profit
Ordinary profit
owners of parent
share(Millions yen)
(Yen)
% (Millions yen)
% (Millions yen)
% (Millions yen)%
Full-year
500,000
3.2
21,00011.7
21,0005.4
12,1002.5
256.16
Note: Revisions made in most recently announced forecasts of business performance: None1

Notes(1) Changes made in significant subsidiaries during consolidated cumulative quarter under review:(2) Special account processing applied in preparation of quarterly consolidated financial statements:(3) Changes made in accounting policies, accounting estimates, and/or restatements:(i) Changes in accounting policies associated with changes in accounting standards, etc.:(ii) Any changes in accounting policies other than those under (i) above:(iii) Changes in accounting estimates:(iv) Restatements:(4) Number of shares issued and outstanding (common shares)(i) Number of shares issued and outstanding
Q2 FY endingat the end of the period (including treasury March 2021
stock)(ii) Number of treasury stock at the end of the Q2 FY ending
March 2021
period(iii) Average number of shares during theQ2 FY ending
March 2021
period (quarterly cumulative total)

None
None
None
None
None
None
None

50,834,700 shares

FY ended March
2020

50,834,700 shares

3,659,527 shares

FY ended March
2020

3,420,627 shares

47,286,744 shares

Q2 FY ended
March 2020

47,630,121 shares* This quarterly summary of financial results is not subject to quarterly review by a Certified Public Accountant or an
audit firm.
* Information on appropriate use of financial forecasts and other special notes:• The forecasts of financial results and other forward-looking statements provided herein are based on information
available to the Company and assumptions considered reasonable at the time this document was prepared. They are
not guarantee that the Company will achieve such forecasts. Actual results may differ significantly from theforecasts for various reasons. For the assumptions on which financial forecasts are based, notes on using financial
forecasts, and other information, please refer to “Information on consolidated financial forecasts and other forwardlooking statements” on page 3 of the attached materials.

2

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

 Index of attached materials
1.

2.

Qualitative information on quarterly results ..................................................................................................... 2(1)

Description of business results ................................................................................................................ 2(2)

Analysis of financial position .................................................................................................................. 3(3)

Information on consolidated financial forecasts and other forward-looking statements .......................... 3

Quarterly consolidated financial statements and notes thereto ......................................................................... 4(1)

Quarterly consolidated balance sheet ....................................................................................................... 4(2)

Quarterly consolidated statement of income and quarterly consolidated statement ofcomprehensive income ............................................................................................................................ 6(3)

Quarterly consolidated statement of cash flows ....................................................................................... 8(4)

Notes on quarterly consolidated financial statements ............................................................................ 10(Notes on the going concern assumption) .............................................................................................. 10(Notes on marked changes to shareholders' equity) ............................................................................... 10(Segment information, etc.) ................................................................................................................... 101

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

1. Qualitative information on quarterly results(1) Description of business results
The Japanese economy has deteriorated rapidly due to the spread of COVID-19, which severely restricted economic andsocial activities, and reduced personal consumption and corporate profits. In addition, the outlook remains uncertain due
to the risk of re-spreading of the infection.
Due to the spread of infectious disease especially at the beginning of the second quarter, the situation in healthcare
industry in which the Group operates has been forced to significantly reduce outpatient and inpatient revenues due torestraint of consultations with medical institutions and a decrease in the number of operations, moreover, thoroughinfection prevention measures and capital investment for related measures are required. As a result of such reasons, thesituation in the industry remains extremely severe.
Under these conditions, Life Care business maintained high occupancy rate and steady growth, and Dispensing Pharmacy
business also performed well in the Group. In addition, due to the need for measures against infectious diseases, new sales
channels have expanded, including the favorable sales of our private brand products such as made-in-Japan surgical mask
"SHIP mask" and low-concentration ozone generator "Airness" series. However, in Total Pack Produce business, theprojects tend to be weighted in the second half as usual. Medical Supply business performed relatively strong, although
the influence of the infectious disease still remained in the second quarter of the current fiscal year.
During this cumulative consolidated second quarter, the various factors noted above resulted in net sales of 220,731
million yen (down 8.9% YoY), operating profit of 7,832 million yen (down 22.3% YoY), ordinary profit of 8,268 million
yen (down 24.8% YoY), and profit attributable to owners of the parent of 4,711 million yen (down 29.6% YoY).
Business results by segment are summarized below.
(i) Total Pack Produce businessIn the second quarter of the previous fiscal year, the recording of large-scale projects were concentrated in the firsthalf of the year unusually and there was a last-minute demand for a consumption tax increase in the manufacturers in
Total Pack Produce business and it performed strong in the quarter. Performance of the newly consolidated medical
device sales subsidiary of Myanmar contributed, however, the projects tend to be weighted in the second half in thesecond quarter of this fiscal year as usual.
As a result, this segment recorded net sales of 36,765 million yen (down 31.7% YoY) and segment profit (operating
profit) of 2,878 million yen (down 46.8% YoY).
(ii) Medical Supply business
In Medical Supply business, despite the impact of the redemption price revision, business performance remained
steady due to the collaboration within the group and improved management efficiency, however, the impact of
temporary decrease in demand for medical materials remained which caused by restraint of consultations withmedical institutions and the decrease in the number of operations due to the spread of COVID-19 at the beginning of
the fiscal year.
As a result, this segment recorded net sales of 154,636 million yen (down 3.7% YoY) and segment profit (operating
profit) of 2,308 million yen (down 6.0% YoY).
(iii) Life Care businessLife Care business performed favorably by the progress of the integrate national wide management and maintenanceof high occupancy rate.
As a result, this segment recorded net sales of 12,262 million yen (up 3.4% YoY) and segment profit (operating
profit) of 1,139 million yen (up 27.6% YoY).
(iv) Dispensing Pharmacy business
Dispensing Pharmacy business performed steadily in the second quarter of this fiscal year since restraint of visit to
medical institutions was eased compared to the beginning of the fiscal year, and also due to the promotion of
infectious disease control products and improvement in management efficiency.
As a result, this segment recorded net sales of 13,205 million yen (down 1.3% YoY) and segment profit (operating
profit) of 1,299 million yen (up 1.5% YoY)(v) Other
The performance of the integrated building management company newly contributed and performed steadily in Other
business.
As a result, this segment recorded net sales of 3,861 million yen (up 52.8% YoY) and segment profit (operating
profit) of 305 million yen (up 57.3% YoY).

2

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(2) Analysis of Financial Position(i) Assets, liabilities, and net assets
Assets at the end of the consolidated cumulative second quarter under review stood at 300,421 million yen, adecrease of 8,451 million yen from the end of the previous consolidated fiscal year. The primary reasons for thisdecrease include increases of 11,351 in investment securities, and 3,198 million yen in merchandise and finishedgoods, despite decreases of 18,705 million yen in cash and deposits, and 9,253 million yen in notes and accounts
receivable - trade.
Liabilities stood at 193,395 million yen, a decrease of 10,796 million yen from the end of the previous consolidated
fiscal year. The primary reasons for this decrease include increases of 3,888 million yen in short-term loans, despite
decreases of 12,138 million yen in notes and accounts payable - trade, and 1,160 million yen in income taxes payable.
Net assets stood at 107,026 million yen, an increase of 2,344 million yen from the end of the previous consolidated
fiscal year. The primary reasons for this increase include increases of 4,711 million yen in retained earnings fromprofit attributable to owners of parent, and 1,775 million yen in valuation differences on available-for-sale securities,
despite decreases of 3,556 million yen in retained earnings due to payment of dividends, and acquisition of 1,078
million yen of treasury stock.
Due to these factors, the equity capital ratio at the end of the consolidated second quarter under review stood at
34.5% (up 1.5 percentage points from the end of the previous consolidated fiscal year).
(ii) Cash flow
Net cash provided by operating activities during the consolidated cumulative second quarter under review totaled
1,835 million yen (down 14,895 million yen from the same period in the previous consolidated fiscal year). Major
contributing factors include decrease 16,300 million yen in notes and accounts payable – trade, payment of 4,489
million yen as income taxes, and decrease of 15,541 million yen in notes and accounts receivable – trade, and recordof 8,098 million yen in profit before income taxes.
Net cash used in investing activities totaled 16,154 million yen (up 13,191 million yen from the same period in theprevious consolidated fiscal year). Major contributing factors include payment of 9,793 million yen in purchase ofshares of subsidiaries and associates, and 4,069 million yen in purchase of shares of subsidiaries resulting in change
in scope of consolidation.
Net cash used in financing activities totaled 4,508 million yen (down 827 million yen from the same period in theprevious consolidated fiscal year). Major contributing factors include proceeds of 1,586 million yen from long-termloans payable and increase of 1,062 million yen in short-term loans, despite payment of 3,556 million yen in dividend
paid, and 2,330 million yen in repayments of long-term loans payable.
As the result of the above factors, the balance of cash and cash equivalents at the end of the consolidated cumulative
second quarter under review stood at 64,076 million yen, down 18,733 million yen from the end of the previous
consolidated fiscal year.

(3) Information on consolidated financial forecasts and other forward-looking statements
In general, business performance matched financial forecasts made at the start of the period. The consolidated financial
forecasts for the full fiscal year remain unchanged from the forecasts announced on May 12, 2020.

3

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

Quarterly consolidated financial statements and notes thereto(4) Quarterly consolidated balance sheet(Unit: Millions yen)
September 30, 2020

March 31, 2020
AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade
Electronically recorded monetary claims - operating
Lease investment assets
Securities
Merchandise and finished goods
Work in process
Raw materials and supplies
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant, and equipment
Buildings and structures, net
Land
Real estate for rent, net
Other, net
Total property, plant, and equipment
Intangible assets
Goodwill
Other
Total intangible assets
Investments and other assets
Investment securities
Long-term loans
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

478,717
95,623
3,611
3,500
5,101
14,029
1,511
845
7,629
(71)
210,499

60,01286,369
3,504
3,433
5,087
17,227
2,094
957
9,614
(114)
188,187

18,534
16,10011,213
11,16657,014

18,233
16,048
11,096
11,49456,873

8,548
972
9,520

10,600987
11,587

14,535
7,810
11,209(1,716)
31,83898,373308,873

25,887
7,667
11,935(1,717)
43,772112,233
300,421

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(Unit: Millions yen)
September 30, 2020

March 31, 2020
Liabilities
Current liabilities
Notes and accounts payable - trade90,121

77,983

Electronically recorded obligations - operating

19,59817,769935

4,823

Income taxes payable

4,400

3,240

Provision for bonuses

2,194

2,174

Other

15,864

16,352

Total current liabilities

133,115

122,343

Bonds with share acquisition rights

25,091

25,079Long-term loans payable

36,98736,407

Net defined benefit liability

2,873

2,900

Asset retirement obligations

838

844

Short-term loans

Non-current liabilities

Other

5,284

5,819

Total non-current liabilities

71,076

71,052

204,191

193,395

Capital stock

15,553

15,553

Capital surplus

23,89523,887Retained earnings

74,84175,996

Treasury stock(14,447)(15,526)

Total shareholders' equity

99,841

99,911

Valuation differences on available-for-sale securities

2,019

3,795

Deferred gains or losses on hedges

－
(152)

(0)
(262)

Total liabilities
Net assets
Shareholders' equity

Accumulated other comprehensive income

Foreign currency translation adjustments
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

5

75

72

1,942

3,604

2,897

3,510

104,681

107,026

308,873

300,421

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(5) Quarterly consolidated statement of income and quarterly consolidated statement of comprehensive
incomeQuarterly consolidated statement of income
Consolidated cumulative second quarter
Six months ended
September 30, 2019242,232(Unit: Millions yen)Six months ended
September 30, 2020
220,731

Cost of sales

217,564

197,475

Gross profit

24,667

23,256

Sales, general, and administrative expenses

14,586

15,423Operating profit

10,081

7,832

Interest income

203

163

Dividend income

193

189

Amortization of negative goodwill

116－

Share of profit of entities accounted for using equity method

22

Foreign exchange gains

6

－
208

Net sales

Non-operating profit

Reversal of allowance for doubtful accounts

360

64

Other

166

277

1,068

902

Interest expenses

126

175

Share of loss of entities accounted for using equity method－

7

Commission paid

3

201

Total non-operating profit
Non-operating expenses

Other

21

81

Total non-operating expenses

151

466

10,9998,268

Gains on sales of non-current assets

1

4

Total extraordinary profit

1

4

Losses on step acquisitions－

92

Losses on sales of non-current assets

2－

Impairment loss－

61

Losses on retirement of non-current assets

019

Losses on valuation of investment securities

0

－

Other

－

0

Total extraordinary losses

3

Ordinary profit
Extraordinary profit

Extraordinary losses

Profit before income taxes

10,997175
8,098

Income taxes - current

3,945

3,118

Income taxes - deferred

317

224

Total income taxes

4,262

3,342

Profit

6,734

4,755

Profit attributable to non-controlling interests
Profit attributable to owners of parent

6

40

43

6,693

4,711

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

Quarterly consolidated statement of comprehensive income
Consolidated cumulative second quarter
Six months ended
September 30, 2019
6,734

(Unit: Millions yen)Six months ended
September 30, 2020
4,755

Valuation differences on available-for-sale securities

492

1,775

Foreign currency translation adjustments

(125)

(174)

Net income
Other comprehensive income

Remeasurements of defined benefit plans

40

Share of other comprehensive income of entities accounted for using equity method－(4)

Total other comprehensive income
Comprehensive income

371

1,597

7,106

6,352

7,115

6,373

(8)

(20)

(Breakdown)Comprehensive income attributable to owners of parent
Comprehensive income attributable to non-controlling interests

7

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(6) Quarterly consolidated statement of cash flows(Unit: Millions yen)Six months ended
September 30, 2020

Six months ended
September 30, 2019
Cash flows from operating activities
Profit before income taxes

10,997

8,098

Depreciation and amortization

1,505

1,494

Amortization of goodwill

－
843

1,012

Amortization of negative goodwill(116)

Share of loss (profit) of entities accounted for using equity method

(22)

－
7

Increase (decrease) in provision for bonuses

(71)

(21)

Increase (decrease) in allowance for doubtful accounts

(533)

(63)

10

40

Interest and dividend income

(397)

(352)

Interest expenses

126

175

4,434

15,54120(3,250)3,165(16,300)

209

67

Impairment loss

Increase (decrease) in net defined benefit liability

Decrease (increase) in notes and accounts receivable – trade
Decrease (increase) in inventories
Increase (decrease) in notes and accounts payable – trade
Decrease (increase) in lease investment assets

61

Other

647

(420)

Subtotal

20,818

6,089

401

410

Interest and dividend income received
Interest expenses paid

(126)

(175)

Income taxes paid

(4,362)(4,489)Net cash provided by operating activities

16,730

1,835

Payments into time deposits

(121)

(121)

Proceeds from withdrawal of time deposits

111

107

Purchase of property, plant, and equipment

Cash flows from investing activities(2,309)(1,858)Proceeds from sales of property, plant, and equipment

156

37

Purchase of intangible assets

(198)

(135)

Payments of short-term loans receivable

(505)

(249)

Collection of long-term loans receivable

1,629

140

Purchase of investment securities(1,087)(207)－(9,793)

117

－

(750)

(4,069)(4)(3)(2,962)(16,154)

Purchase of shares of subsidiaries and associates
Proceeds from shares of subsidiaries resulting in change inscope of consolidation
Purchase of shares of subsidiaries resulting in change inscope of consolidation
Other
Net cash used in investing activities

8

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(Unit: Millions yen)Six months ended
September 30, 2020

Six months ended
September 30, 2019
Cash flows from financing activities(270)

Increase (decrease) in short-term loans-net

1,062

Proceeds from long-term loans payable

800

1,586

Repayments of long-term loans payable(3,058)(2,330)(0)(1,078)(3,334)(3,556)

Cash dividends paid to non-controlling interests

(90)

(69)

Proceeds from issuance to non-controlling shareholders

731

Repayments of lease obligations

(113)

－
(122)

－

0

(5,335)(4,508)(32)

94

Net increase (decrease) in cash and cash equivalents

8,399(18,733)

Cash and cash equivalents at the beginning of the period

71,49482,810Cash and cash equivalents at the end of the period

79,89464,076

Purchase of treasury stock
Cash dividends paid

Other
Net cash used in financing activities
Effect of exchange rate change on cash and cash equivalents

9SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

(7) Notes on quarterly consolidated financial statements(Notes on the going concern assumption)
Not applicable(Notes on marked changes to shareholders' equity)
Not applicable(Segment information, etc.)[Segment information]
I
1

Six months ended September 30, 2019 (April 1 – September 30, 2019)
Net sales and profit (loss) by reportable segment(Unit: Millions yen)
Reconciliation*2

Amountrecorded inquarterly
consolidated
incomestatement*3

Reportable segment
Total Pack
Producebusiness

MedicalSupplybusiness

Life Carebusiness

Dispensing
Pharmacybusiness

Subtotal

Other*1

Total

Net sales(1) Sales to outside
customers(2) Intersegment
sales or transfers
Subtotal

53,857

160,607

11,86013,380239,705

2,526

242,232－

242,232

1,180

559

109

1,149

2,999

158

3,157

(3,157)－55,038161,166

11,97014,529242,704

2,685

245,390(3,157)242,232

Segment profit
5,406
2,455
892
1,280
10,035
194
10,229(147)
10,081
Notes:
1. The “Other” category includes businesses that are not included in reportable segments, including the veterinary clinic
business, sales of physical and chemical apparatus business, and the security business.
2. Reconciliation items for segment profit of ¥(147) million include intersegment elimination of ¥(41) million and corporate
expenses not allocated to the reportable segments of ¥(105) million. Corporate expenses consist primarily of operating
expenses of the Company’s head office and selling, general, and administrative expenses that are not attributable to any
reportable segments.
3. Segment profit is reconciled to the operating profit reported in the quarterly consolidated statement of income.
2

Information on impairment loss on non-current assets and goodwill by each reporting segment
No significant impairment losses on non-current assets, significant changes in amounts of goodwill, or significant gains on
bargain purchases were recognized during the six months ended second quarter-end.

10

SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements
for Second Quarter of Fiscal Year Ending March 31, 2021

II

Six months ended September 30, 2020 (April 1 – September 30, 2020)

1

Net sales and profit (loss) by reportable segment(Unit: Millions yen)
Reconciliation*2

Amountrecorded inquarterly
consolidated
incomestatement*3

Reportable segment
Total Pack
Producebusiness

MedicalSupplybusiness

Life Carebusiness

Dispensing
Pharmacybusiness

Subtotal

Other*1

Total

Net sales(1) Sales to outside
customers(2) Intersegment
sales or transfers
Subtotal

36,765

154,636

12,262

13,205

216,870

3,861

220,731－

220,731

1,046

968

113

12,837

14,965221

15,186(15,186)－

37,812

155,604

12,37526,042

231,835

4,082

235,918(15,186)

220,731

Segment profit
2,878
2,308
1,139
1,299
7,627
305
7,933
(100)
7,832
Notes:
1. The “Other” category includes businesses that are not included in reportable segments, including the veterinary clinic
business, sales of physical and chemical apparatus business, and the security business.
2. Reconciliation items for segment profit of ¥(100) million include intersegment elimination of ¥(25) million and corporate
expenses not allocated to the reportable segments of ¥(71) million. Corporate expenses consist primarily of operating
expenses of the Company’s head office and selling, general, and administrative expenses that are not attributable to any
reportable segments.
3. Segment profit is reconciled to the operating profit reported in the quarterly consolidated statement of income.
2

Information on assets by each reporting segment
During the second quarter of the current consolidated cumulative period, the Company acquired the shares of STK Co., Ltd.
and it is included in the scope of consolidation. The Company also acquired equity interests of Charm Care Corporation.,and it is included in the scope the equity-method applied.
Due to the above acquisition, assets in “Life Care business” segment increased by 9,859 million yen from the end of theprevious consolidated fiscal year.

3

Information on impairment loss on non-current assets and goodwill by each reporting segment(Significant impairment losses on non-current assets)
Not applicable.
(Significant changes in the amount of goodwill)
During the second quarter of the current consolidated cumulative period, the Company acquired the shares of Okkar Thiri
Co., Ltd. and Snow Everest Co., Ltd., and they are included in the scope of consolidation.
The increase in goodwill in “Total Pack Produce business” segment due to the above event is 3,013 million yen.
(Significant gain on negative goodwill)
Not applicable.

11